ZVSA
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. (ZVSA)
$10
About ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. (ZVSA)
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Lighthouse Point, FL.
Details
Daily high
$0.10
Daily low
$0.10
Price at open
$0.10
52 Week High
$0.30
52 Week Low
$0.08
Market cap
801,500
Dividend yield
-
Volume
14,517
Avg. volume
5,485
P/E ratio
-.03
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. News
Details
Daily high
$0.10
Daily low
$0.10
Price at open
$0.10
52 Week High
$0.30
52 Week Low
$0.08
Market cap
801,500
Dividend yield
-
Volume
14,517
Avg. volume
5,485
P/E ratio
-.03